Study estimates 76 % of the Brazilian city exposed to SARS-COV-2

In a study published in Science on December 8, a research organization estimates that 76% of the population of Manaus, the first Brazilian city to be hit hard by the coronavirus pandemic, may have been infected with SARS. -Cov-virus. 2 so far. The antibody-based matrix provides blood bank samples. The report also estimates that in São Paulo, Brazil’s largest city, this age % is much lower, accounting for 29% of the population. According to the newspaper, these effects highlight Manaus’ failure to spread the virus.

The findings are based on the analysis of samples from donor blood centers. Because Brazilian law establishes that blood banks should keep samples for six months, the researchers were able to go back in time and trace the unravelling of the pandemic between February and October. In the case of Manaus, they …

The cell phone stains the hood

Understanding the Role of Autophagy in Infectious Disease

Improvement of the specificity of mobile T tumors in a single coculture.

Autoimmune diseases: application of immunotherapy

Genetics and tolerance shake up how alcohol affects a person, creating a unique cocktail of experiences.

Experts from the Women’s Brain Foundation and bit.bio will explore the importance of sex-specific in vitro models for neurological research and drug discovery.

Discover how scientists are designing the next groundbreaking vaccines against infectious diseases.

In this webinar, Linghua Wang and Jeremy Goecks will talk about technology that enables new approaches for a better understanding of tumors on a cellular, spatial, and environmental level.

Explore how researchers use organoids to understand tissue regeneration and develop novel therapies.

A collaborative assignment with the global leader in AI informatics demonstrates synthetic workflows and style integration for autonomous generative virtual detection in drug discovery. The corporation also announces key accreditations in the popularity of excellence in knowledge security, AI innovation and commitment to non-stop improvement.

The combination completes proteomics based on SAPIENT mass spectrometry, expands multi-ordinary responses and will allow the progression of nullisaseq ™ tests under regulated direction.

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the launch of Vericheck ddPCR™ Empty-Full Capsid Kits for adeno-associated virus (AAV) serotypes 2 and 8, enabling determination of capsid titer, genome titer, and percentage of full capsids in purified or unpurified (crude lysate) samples.

Scientists overcome the demanding situations of detecting mycoplasma contamination in complex treatment drugs using tailor-made nucleic acid extraction and amplification strategies.

© 1986-2025 The Scientist. All rights reserved.

Leave a Comment

Your email address will not be published. Required fields are marked *